维普期刊资源整合服务平台（V6.5）

73篇 您的检索式：作者名="Witzig T"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience显示文摘	Phil A Hart Mark D Topazian Thomas E Witzig Jonathan E Clain Ferga C Gleeson Robin R Klebig Michael J Levy Randall K Pearson Bret T Petersen Thomas C Smyrk Aravind Sugumar Naoki Takahashi Santhi S Vege Suresh T Chari	2013	Gut2013，，11：	2
2	Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience显示文摘	Phil A Hart Mark D Topazian Thomas E Witzig Jonathan E Clain Ferga C Gleeson Robin R Klebig Michael J Levy Randall K Pearson Bret T Petersen Thomas C Smyrk Aravind Sugumar Naoki Takahashi Santhi S Vege Suresh T Chari	2013	Gut2013，，11：	2
3	Review of 1027 patients with newly diagnosed multiple myeloma显示文摘	KYLE R A GERTZ M A WITZIG T E	2003	Mayo Clin Proc2003，78，1：	1
4	Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma显示文摘	Kumar S Witzig T E Dispenzieri A		0，，：	1
5	Introduction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents显示文摘	Witzig T E Timm M Stenson Mary	2000	Clinical Cancer Research2000，6，2：	1
6	Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity显示文摘	Mathew P Ahmann G J Witzig T E	1995	Br J Haematol1995，90，：	1
7	The role of adhesion receptors in the pathogenesis of multiple myeloma显示文摘	WITZIG T E	1999	Hematol Oncol Clin North Am1999，13，：	1
8	Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's lymphoma显示文摘	Witzig TE Wiernik PH Moore T	2009	J Clin Oncol2009，27，：	1
9	Inhibition of the phosphatidylinositol 3-kinase/mamm-alian target of rapamycin pathway in hematologic malignancies显示文摘	Witzig T E Kaufmann S H	2006	Curr Treat Options Oncol2006，7，：	1
10	Yttrium -90 Ibritumomab Tiuxetan induces long - term durable responses in patients with relapsed or refracto- ry B - cell non - Hodgkin's lymphoma显示文摘	Wiseman G Witzig T	2005	Cance Biother Radiopharm2005，20，2：	1
11	Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for patients with relapsed CD20+ B-cell non-Hodgkin's lymphoma显示文摘	Alcindor T Witzig TE	2002	Curr Treat Options Oncol2002，3，4：	1
12	Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma 显示文摘	Thompson M A Witzig T E Kumar S	2003	Br J Haematol2003，123，2：	1
13	Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy 显示文摘	Witzig T E Bossy B Kimlinger T	2002	Clin Cancer Res2002，8，：	1
14	Targeting apoptosis pathways in cancer therapy显示文摘	Ghobrial I M Witzig T E Adjei A A	2005	CA Cancer J Clin2005，55，3：	1
15	Efficacy and safety of lenaiidomide oral monotherapy in patients with relapsed or refractory mantle cell lymphoma: results of an international study (NHL- 003 ) 显示文摘	Zinzani PL Witzig T Vose JM	2008	Blood2008，112，：	1
16	Targeting apoptosis pathways in cancer therapy 显示文摘	GHOBRIAL I M WITZIG T E ADJEI A A	2005	CA Cancer J Clin2005，55，3：	1
17	Randomized controlled trial of yttrium-90 labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma显示文摘	WITZIG T E GORDON L I CABANILLAS F	2002	J Clin Oncol2002，20，：	1
18	Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma显示文摘	Witzig TE Wiernik PH Moore T	2009	J Clin Oncol2009，27，32：	1
19	Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma 显示文摘	EMMANOUILIDES C WITZIG T E GORDON L I	2006	Leuk Lymphoma2006，47，：	1
20	Targeting Apoptosis Pathways in Cancer Therapy 显示文摘	GHOBRIAL I M WITZIG T E ADJEI A A	2005	Cancer J Clin2005，55，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示